|
Volumn 153, Issue 5, 2012, Pages 1128-1129
|
Katz et al., Efficacy and safety of tanezumab in the treatment of chronic low back pain [Pain 2011;152:2248-2258] and Hill, Blocking the effects of NGF as a route to safe and effective pain relief - Fact or fancy? [Pain 2011;152:2200-2201]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CALCITONIN GENE RELATED PEPTIDE;
NERVE GROWTH FACTOR;
SUBSTANCE P;
TANEZUMAB;
ANALGESIA;
ARTHRALGIA;
DRUG EFFICACY;
DRUG SAFETY;
HUMAN;
INNERVATION;
LETTER;
LOW BACK PAIN;
PRIORITY JOURNAL;
ANALGESICS, NON-NARCOTIC;
ANTIBODIES, MONOCLONAL, HUMANIZED;
CHRONIC PAIN;
FEMALE;
HUMANS;
LOW BACK PAIN;
MALE;
|
EID: 84859911701
PISSN: 03043959
EISSN: 18726623
Source Type: Journal
DOI: 10.1016/j.pain.2012.02.032 Document Type: Letter |
Times cited : (8)
|
References (7)
|